J3145 HCPCS Level II code: Injection, testosterone undecanoate, 1 mg

J3145 is the HCPCS code for “Injection, testosterone undecanoate, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J3145

Injection, testosterone undecanoate, 1 mg

Short description: Testosterone undecanoate 1mg

HCPCS · United States

Notes for J3145

As CMS prints them, with any note J3145 takes from the headings above it.

Note

  • CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.

Medicare details

The indicators CMS publishes with J3145 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care
BETOS category
Other drugs
Added
Jan 1, 2015

Where J3145 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J3145Injection, testosterone undecanoate, 1 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J3145 mean?

J3145 is the HCPCS code for “Injection, testosterone undecanoate, 1 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J3145?

CMS lists J3145’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.